bearish

Lagging behind in the cloud rush, R&D underspent, M&As to mitigate? Avoid.

336 Views17 Apr 2015 16:13
We think the IPO is fairly valued and are concerned about its eroding market share. We would avoid this IPO:  MYOB is a market leader in accounting...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Ke Yan, CFA, FRM
Asia Pac IPO & Placement Research, China biotech
Aequitas Research
EquitiesEquity Capital MarketsQuantitative Analysis
Price Chart(Sign Up to Access)
analytics-chart
  • Lagging behind in the cloud rush, R&D underspent, M&As to mitigate? Avoid.
    17 Apr 2015
x